Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00492583 · ClinicalTrials.gov registry record · Phase 3

Study to Investigate the Potential of Probiotics in Yogurt

A Phase 3 study of Healthy, sponsored by Georgetown University.

Completed
Registry status
Phase 3
Development phase
182
Enrollment target
1
Study location

NCT00492583: Completed Phase 3 study of Healthy, sponsored by Georgetown University.

NCT00492583 is a Phase 3 study of Healthy that has completed, run by Georgetown University. The registered enrollment target is 182 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00492583, a Phase 3 study of Healthy, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
Phase 3
Development phase
182 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the consumption of a yogurt drink containing a high dose of probiotics decreases absences, due to illnesses, in daycare centers for children between the ages of 1 and 3.

Primary Outcome

Outcome measure, "number of days children are out of school sick" was measured for the entire population

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Bifidobacterium lactis (BB-12)

Study Locations (1)

District of Columbia

  • Georgetown University Department of Family Medicine - Washington D.C.

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2007-07
Est. Completion 2008-08
Phase Phase 3
Georgetown University

227 total trials

What the finished NCT00492583 record still lists

NCT00492583 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00492583 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00492583 about?

NCT00492583 is a clinical study titled "Study to Investigate the Potential of Probiotics in Yogurt". The purpose of this study is to determine if the consumption of a yogurt drink containing a high dose of probiotics decreases absences, due to illnesses, in daycare centers for children between the ages of 1 and 3.

What is the current status of trial NCT00492583?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2007-07. Estimated completion is 2008-08.

What conditions does trial NCT00492583 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00492583?

The interventions under investigation include: Placebo (DRUG), Bifidobacterium lactis (BB-12) (DRUG).

Who is sponsoring clinical trial NCT00492583?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00492583 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00492583's enrollment target sits among peer trials

182 133rd of 1090 higher than 958 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03897998 · 182 participants · Phase 2

    Neural Correlates of Hypoalgesia Driven by Observation

  • NCT04300556 · 182 participants · Phase 1

    A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  • NCT04323735 · 182 participants · Phase 2

    Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters

  • NCT05606731 · 182 participants · NA

    Family Intervention to Prevent Childhood Obesity

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00492583, the US trial registry maintained by the National Library of Medicine. NCT00492583 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.